Wordt geladen...
A FOUR-GENE BIOMARKER PREDICTS SKIN DISEASE IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
BACKGROUND: Improved outcome measures in systemic sclerosis are critical to finding active therapeutics for this disease. The modified Rodnan skin score (MRSS) is the current standard for evaluation of skin disease in systemic sclerosis, but is not commonly employed in the clinical setting in part b...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3018285/ https://ncbi.nlm.nih.gov/pubmed/20112379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.27220 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|